Literature DB >> 10505969

Technical validation of low-cost videoconferencing systems applied in orthopaedic teleconsulting services.

P Mattioli1, P J Klutke, F Baruffaldi, A Villar-Guzman, A Toni, K H Englmeier.   

Abstract

Investigation on the applicability of low-cost videoconferencing (VC) for health care services is becoming a real need. Reduced resources drive the administrators to evaluate inexpensive solutions for telemedicine. Considering this scenario, this work is a preliminary step to validate, from a technical point of view, if low-cost VC systems could be suitable for orthopaedic teleconsulting services. For this purpose, four different videoconferencing systems were tested. Each VC system was composed of a computer and a VC device installed in. VC devices were chosen among the most popular and distributed products (made by Intel, PictureTel and Aethra). The Telemedicine Benchmark, a specific tool defined by the authors, was applied to measure the overall systems performances in terms of time delays during basic rate ISDN connections (128 Kbit/s). Results showed that it is possible to apply low-cost videoconferencing systems for orthopaedic teleconsulting services. Most of the systems provided acceptable performance for medical image visualization and real time joint working. Further developments are recommendable to enhance the VC software tools capabilities and to improve software-user interface. reserved.

Mesh:

Year:  1999        PMID: 10505969     DOI: 10.1016/s0169-2607(99)00029-2

Source DB:  PubMed          Journal:  Comput Methods Programs Biomed        ISSN: 0169-2607            Impact factor:   5.428


  2 in total

Review 1.  Theory and applications of telemedicine.

Authors:  Nihal Fatma Güler; Elif Derya Ubeyli
Journal:  J Med Syst       Date:  2002-06       Impact factor: 4.460

2.  Orthopedic Telemedicine Outpatient Practice Diagnoses Set during the First COVID-19 Pandemic Lockdown-Individual Observation.

Authors:  Wojciech Michał Glinkowski
Journal:  Int J Environ Res Public Health       Date:  2022-04-29       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.